AFT first-half net profit fell 66%, even as sales lifted 18%

AFT first-half net profit fell 66%, even as sales lifted 18%
Chair David Flacks said it's appropriate to invest more to spur growth. (Image: Supplied)
Jenny Ruth
AFT Pharmaceuticals' first-half net profit fell by 66% despite a more than 18% jump in revenue and a 30% growth in product sales and royalties, and it downgraded guidance for the full year.AFT also downgraded guidance provided in May and now expected operating profit of between $18 million and $23m for the full year ending March 2023, down from between $27m to $32m, saying that reflected growth investments and deferred license income due to the delay in Maxigesic IV getting US registration.However, the company is still expecting to pay a ma...

More Markets

Oceania Healthcare extends dividend freeze
Markets

Oceania Healthcare extends dividend freeze

The retirement village operator hasn't paid a dividend since June 2023.

Reform wave reshapes energy sector as investors circle NZ
Infrastructure

Reform wave reshapes energy sector as investors circle NZ

Nearly half of surveyed offshore investors planning an acquisition.

Emissions intensity: Who’s clean, who’s carbon-heavy
Markets Carbon Catch-Up

Emissions intensity: Who’s clean, who’s carbon-heavy

Twenty-four companies with available data improved their emissions intensity.

WasteCo’s truck/toilet plan, Radius wants to grow West Coast
Markets Small Cap Wrap

WasteCo’s truck/toilet plan, Radius wants to grow West Coast

Plus: who got more money from investors, who tapped a twosome, and more.